Novartis Healthcare Private Ltd (NHPL) has launched the Sequadra Inhaler (indacaterol/glycopyrronium) 110mcg/50mcg, a treatment for chronic obstructive pulmonary disease (COPD), which is a fixed dose combination of 2 bronchodilating compounds: indacaterol maleate, a long-acting ... Read more